CORTICEIRAAMORIM SA financials
CORTICEIRAAMORIM SA
Country: PT Reporting currency: EUR Latest annual report: 2022-12-31
LEI:
213800J5M11TDEP3LQ76 ISIN: PTCOR0AE0006 Financial statements
(EUR, as reported — unscaled; 107 line items across 2 annual periods)
| Line item | 2022 | 2021 |
|---|---|---|
| Income statement | ||
| Revenue | €1.02B | €837.8M |
| Cost of sales | €512.1M | €410.4M |
| Other income | €20.9M | €11.9M |
| Employee benefits expense | €182.9M | €146.1M |
| Depreciation & amortisation | €48.6M | €40.7M |
| Operating profit (EBIT) | €115.3M | €93.7M |
| Finance costs | €3.4M | €1.7M |
| Profit before tax | €116.6M | €101.5M |
| Income tax expense | €5.9M | €18.4M |
| Profit for the year | €110.6M | €83.0M |
| — attributable to owners | €98.4M | €74.8M |
| — attributable to NCI | €12.2M | €8.3M |
| Total comprehensive income | €115.0M | €84.4M |
| Per share | ||
| Basic EPS | €0.74 | €0.56 |
| Diluted EPS | €0.74 | €0.56 |
| Free cash flow / share | €-0.00 | €0.82 |
| Cash flow statement | ||
| Cash generated from operations | €28.6M | €106.2M |
| Net cash from operating activities | €92.9M | €157.6M |
| Net cash from investing activities | -€131.6M | -€53.7M |
| Purchase of PP&E (capex) | €93.3M | €36.0M |
| Purchase of intangibles | €3.8M | €5.6M |
| Net cash from financing activities | €7.1M | -€61.2M |
| Dividends paid | €44.1M | €38.1M |
| Proceeds from borrowings | €71.7M | €22.4M |
| Repayments of borrowings | €21.0M | €41.5M |
| Lease liability payments | €2.9M | €2.8M |
| Net change in cash | -€31.7M | €42.7M |
| Balance sheet | ||
| Total assets | €1.27B | €1.08B |
| Non-current assets | €492.7M | €382.3M |
| Property, plant & equipment | €392.6M | €284.0M |
| Intangible assets & goodwill | €18.9M | €9.8M |
| Current assets | €776.6M | €699.0M |
| Inventories | €405.2M | €340.2M |
| Trade & other receivables | €207.8M | €182.7M |
| Cash & equivalents | €84.9M | €109.6M |
| Total equity | €744.9M | €623.3M |
| Non-controlling interests | €79.3M | €27.3M |
| Non-current liabilities | €167.9M | €159.1M |
| Long-term borrowings | €104.9M | €87.6M |
| Current liabilities | €356.5M | €298.9M |
| Deferred tax liabilities | €44.0M | €51.0M |
| Derived metrics | ||
| Free cash flow | -€458.0K | €121.6M |
| Operating margin | 11.3% | 11.2% |
| Net margin | 10.8% | 9.9% |
| Return on equity | 14.9% | 13.3% |
| Cash conversion ratio | 0.84× | 1.90× |
| Capex coverage | 1.00× | 4.38× |
| Other reported items | ||
| Cash and Cash Equivalents If Different From Statement of Financial Position | €35.3M | €67.1M |
| Changes In Inventories of Finished Goods and Work In Progress | -€14.5M | €11.6M |
| Comprehensive Income Attributable To Noncontrolling Interests | €12.5M | €7.3M |
| Comprehensive Income Attributable To Owners of Parent | €102.5M | €77.1M |
| Current Borrowings and Current Portion of Noncurrent Borrowings | €109.0M | €70.1M |
| Current Tax Assets Current | €12.4M | €10.4M |
| Current Tax Liabilities Current | €6.7M | €4.4M |
| Deferred Tax Assets | €13.2M | €12.1M |
| Dividends Paid To Equity Holders of Parent Classified As Financing Activities | €38.6M | €35.9M |
| Dividends Paid To Noncontrolling Interests Classified As Financing Activities | €5.5M | €2.2M |
| Dividends Received Classified As Investing Activities | €1.2M | €1.8M |
| Dividends Recognised As Distributions To Owners Per Share | €0.29 | — |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -€34.0K | €42.0K |
| Equity and Liabilities | €1.27B | €1.08B |
| Finance Income | €590.0K | €102.0K |
| Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €157.0K | -€2.2M |
| Income Taxes Paid Refund Classified As Operating Activities | €13.1M | €18.5M |
| Increase Decrease Through Appropriation of Retained Earnings | €0 | €0 |
| Increase Decrease Through Changes In Ownership Interests In Subsidiaries That Do Not Result In Loss of Control | €5.3M | €313.0K |
| Intangible Assets Other Than Goodwill | €22.0M | €17.3M |
| Interest Paid Classified As Financing Activities | €2.5M | €1.6M |
| Interest Received Classified As Investing Activities | €549.0K | €84.0K |
| Investment Accounted For Using Equity Method | €32.1M | €42.4M |
| Investment Property Completed | €4.0M | €5.3M |
| Issued Capital | €133.0M | €133.0M |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale | €298.0K | €0 |
| Noncurrent Biological Assets | €913.0K | €62.0K |
| Noncurrent Provisions For Employee Benefits | €2.6M | €2.2M |
| Other Cash Payments To Acquire Equity Or Debt Instruments of Other Entities Classified As Investing Activities | €44.8M | €15.5M |
| Other Cash Receipts From Sales of Equity Or Debt Instruments of Other Entities Classified As Investing Activities | €137.0K | €44.0K |
| Other Comprehensive Income | €4.4M | €1.4M |
| Other Comprehensive Income Net of Tax Cash Flow Hedges | €732.0K | -€540.0K |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | €2.1M | €665.0K |
| Other Current Assets | €24.1M | €9.6M |
| Other Current Financial Liabilities | €46.9M | €45.8M |
| Other Current Liabilities | €23.5M | €17.7M |
| Other Expense By Nature | €11.2M | €6.9M |
| Other Individually Immaterial Components of Other Comprehensive Income Net of Tax | €246.0K | -€460.0K |
| Other Inflows Outflows of Cash Classified As Operating Activities | €77.4M | €70.0M |
| Other Longterm Provisions | €4.5M | €3.7M |
| Other Noncurrent Financial Assets | €1.9M | €1.9M |
| Other Noncurrent Financial Liabilities | €11.9M | €14.6M |
| Other Noncurrent Receivables | €2.5M | €3.2M |
| Payments From Changes In Ownership Interests In Subsidiaries | €5.0M | €5.0M |
| Payments To and On Behalf of Employees | €173.0M | €141.2M |
| Payments To Suppliers For Goods and Services | €882.0M | €631.3M |
| Proceeds From Contributions of Noncontrolling Interests | €7.2M | €49.0K |
| Proceeds From Government Grants Classified As Financing Activities | €4.2M | €5.6M |
| Proceeds From Other Longterm Assets Classified As Investing Activities | €1.0M | €222.0K |
| Proceeds From Sales of Intangible Assets Classified As Investing Activities | €292.0K | €377.0K |
| Proceeds From Sales of Investment Property | €4.8M | €0 |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | €2.7M | €876.0K |
| Purchase of Other Longterm Assets Classified As Investing Activities | €330.0K | €0 |
| Receipts From Sales of Goods and Rendering of Services | €1.08B | €878.7M |
| Retained Earnings Profit Loss For Reporting Period | €98.4M | €74.8M |
| Rightofuse Assets That Do Not Meet Definition of Investment Property | €4.6M | €6.2M |
| Services Expense | €186.5M | €142.6M |
| Share of Other Comprehensive Income of Associates and Joint Ventures Accounted For Using Equity Method | €1.2M | €1.7M |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | €4.8M | €3.0M |
| Trade and Other Current Payables To Trade Suppliers | €170.5M | €160.8M |
Methodology
Every line item above is a fact tagged in CORTICEIRAAMORIM SA's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.